SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 17 filers reported holding SUMMIT THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,000 | – | 1,961 | +880.5% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 200 | -89.5% | 0.00% | – |
Q2 2019 | $2,000 | -90.5% | 1,900 | -83.5% | 0.00% | – |
Q1 2019 | $21,000 | -81.6% | 11,500 | -75.4% | 0.00% | – |
Q2 2018 | $114,000 | -85.2% | 46,800 | -21.8% | 0.00% | – |
Q1 2018 | $771,000 | +81.8% | 59,837 | +56.3% | 0.00% | – |
Q4 2017 | $424,000 | -8.8% | 38,291 | +3.3% | 0.00% | – |
Q3 2017 | $465,000 | +474.1% | 37,072 | +419.1% | 0.00% | – |
Q2 2017 | $81,000 | +20.9% | 7,142 | +37.9% | 0.00% | – |
Q1 2017 | $67,000 | +123.3% | 5,178 | +43.4% | 0.00% | – |
Q4 2016 | $30,000 | -44.4% | 3,610 | -40.3% | 0.00% | – |
Q3 2016 | $54,000 | +22.7% | 6,049 | +6.1% | 0.00% | – |
Q2 2016 | $44,000 | – | 5,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Granite Point Capital Management, L.P. | 127,841 | $1,331,000 | 0.91% |
SPHERA FUNDS MANAGEMENT LTD. | 205,200 | $2,136,000 | 0.27% |
LANSDOWNE PARTNERS (UK) LLP | 930,000 | $9,681,000 | 0.08% |
Point72 Asset Management, L.P. | 919,639 | $9,573,000 | 0.08% |
EverPoint Asset Management, LLC | 100,000 | $1,041,000 | 0.03% |
AXA S.A. | 376,205 | $3,916,000 | 0.02% |
First Eagle Investment Management, LLC | 175,000 | $1,822,000 | 0.01% |
Tower Research Capital LLC (TRC) | 1,228 | $13,000 | 0.00% |
UBS Group AG | 880 | $9,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 2,500 | $26,000 | 0.00% |